文献速递脊柱关节炎类风湿关节炎

患者与评估者整体评估不一致对14868例脊柱关节炎患者治疗结局的影响

Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

结果显示,基线ΔPEG越高,6/12/24个月TNFi保留率及多数缓解指标越差,且女性患者保留率和缓解率总体低于男性。

要点

  • 基线ΔPEG较高与PsA和axSpA患者6/12/24个月TNFi保留率降低相关(P<0.001)。
  • axSpA中ΔPEG较高与BASDAI<2和ASDAS<1.3缓解率降低相关。
  • PsA中ΔPEG较高与DAS28CRP(4)<2.6和DAPSA28≤4缓解率降低相关,但DAS28CRP(3)<2.6无显著关联。

核心结论

  • 基线患者整体评估高于评估者整体评估与PsA和axSpA患者首次TNFi的6/12/24个月保留率及缓解率降低相关。

研究设计与样本

  • 按基线ΔPEG四分位数分组,采用Kaplan-Meier分析和log-rank检验及Cox回归比较保留率,采用χ2检验和logistic回归比较缓解率,并分性别分析。

主要发现

  • 基线ΔPEG与女性和男性PsA及axSpA患者6/12/24个月TNFi保留率呈负相关(P<0.001)。
  • 在axSpA患者中,基线ΔPEG与6/12/24个月BASDAI<2(P≤0.002)和ASDAS<1.3(P≤0.005)缓解率呈负相关。
  • 在PsA患者中,基线ΔPEG与DAS28CRP(4)<2.6(P≤0.04)和DAPSA28≤4(P≤0.01)缓解率呈负相关,但与DAS28CRP(3)<2.6无显著关联(P≥0.13)。
  • 女性患者TNFi保留率和缓解率总体低于男性患者。

关键数值与推荐

  • 基线ΔPEG定义为患者整体评估减评估者整体评估的差值。
  • axSpA缓解标准包括BASDAI<2和ASDAS<1.3;PsA缓解标准包括DAS28CRP(4)<2.6、DAS28CRP(3)<2.6和DAPSA28≤4。
  • 保留率评估时间点为6、12、24个月。

临床怎么用

  • 临床中应关注患者与评估者整体评估的差异,基线ΔPEG较高可能提示TNFi治疗保留和缓解概率较低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the impact of 'patient's minus evaluator's global assessment of disease activity' (ΔPEG) at treatment initiation on retention and remission rates of TNF inhibitors (TNFi) in psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) patients across Europe. METHODS: Real-life data from PsA and axSpA patients starting their first TNFi from 11 countries in the European Spondyloarthritis Research Collaboration Network were pooled. Retention rates were compared by Kaplan-Meier analyses with log-rank test and by Cox regression, and remission rates by χ2 test and by logistic regression across quartiles of baseline ΔPEG, separately in female and male PsA and axSpA patients. RESULTS: We included 14 868 spondyloarthritis (5855 PsA, 9013 axSpA) patients. Baseline ΔPEG was negatively associated with 6/12/24-months' TNFi retention rates in female and male PsA and axSpA patients (P <0.001), with 6/12/24-months' BASDAI < 2 (P ≤0.002) and ASDAS < 1.3 (P ≤0.005) in axSpA patients, and with DAS28CRP(4)<2.6 (P ≤0.04) and DAPSA28 ≤ 4 (P ≤0.01), but not DAS28CRP(3)<2.6 (P ≥0.13) in PsA patients, with few exceptions on remission rates. Retention and remission rates were overall lower in female than male patients. CONCLUSION: High baseline patient's compared with evaluator's global assessment was associated with lower 6/12/24-months' remission as well as retention rates of first TNFi in both PsA and axSpA patients. These results highlight the importance of discordance between patient's and evaluator's perspective on disease outcomes.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Michelsen B, Ørnbjerg LM, Kvien TK, et al. Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis. Rheumatology (Oxford). 2020. PMID: 31960053. doi:10.1093/rheumatology/kez656

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。